Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02301130 · ClinicalTrials.gov registry record · Phase 1

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumors, sponsored by Kyowa Kirin.

Completed
Registry status
Phase 1
Development phase
64
Enrollment target
7
Study locations

NCT02301130 is a Phase 1 study of Advanced Solid Tumors that has completed, run by Kyowa Kirin. The registered enrollment target is 64 participants, below the 198-participant average among 144 other Advanced Solid Tumors trials with a reported enrollment target (68% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02301130, a Phase 1 study of Advanced Solid Tumors, has completed, sponsored by Kyowa Kirin.

COMPLETED
Registry status
Phase 1
Development phase
64 participants
Enrollment target
7
Study locations

Study Summary

Mogamulizumab in Combination with MEDI4736 (Durvalumab) and Mogamulizumab in Combination with Tremelimumab in Subjects with Advanced Solid Tumors

Conditions Studied

Advanced Solid Tumors

Interventions

  • BIOLOGICAL MEDI4736 (Durvalumab)
  • BIOLOGICAL mogamulizumab
  • BIOLOGICAL tremelimumab

Study Locations (7)

California

  • The Angeles Clinic - Los Angeles
  • UCLA Hematology & Oncology Clinic - Los Angeles

Connecticut

  • Yale Cancer Center - New Haven

Florida

  • H. Lee Moffitt Cancer Center - Tampa

Georgia

  • Georgia Cancer Center - Augusta

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2014-11-26
Est. Completion 2018-03-05
Phase Phase 1

Sponsor

Kyowa Kirin

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02301130

The ClinicalTrials.gov registry entry for NCT02301130 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 198-participant average among 144 other Advanced Solid Tumors trials with a reported enrollment target (68% lower). The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumors appearing as the primary indexed condition, and to 3 interventions - of which MEDI4736 (Durvalumab) is the first listed.

NCT02301130 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Connecticut, Florida.

Frequently Asked Questions

What is clinical trial NCT02301130 about?

NCT02301130 is a clinical study titled "Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors". Mogamulizumab in Combination with MEDI4736 (Durvalumab) and Mogamulizumab in Combination with Tremelimumab in Subjects with Advanced Solid Tumors

What is the current status of trial NCT02301130?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2014-11-26. Estimated completion is 2018-03-05.

What conditions does trial NCT02301130 study?

This clinical trial studies the following conditions: Advanced Solid Tumors.

What interventions are being tested in trial NCT02301130?

The interventions under investigation include: MEDI4736 (Durvalumab) (BIOLOGICAL), mogamulizumab (BIOLOGICAL), tremelimumab (BIOLOGICAL).

Who is sponsoring clinical trial NCT02301130?

This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02301130 being conducted?

This trial has 7 study locations across California, Connecticut, Florida, Georgia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumors

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.